- Home
- Primary Care
- Patient Case Based on Xanomeline-Trospium Chloride in Schizophrenia: Advancing Treatment for Resistant Symptoms

3d3 min read
Medical Article
Introduction Schizophrenia is a chronic psychiatric disorder marked by hallucinations, delusions, and cognitive deficits, affecting about 1% of the population (1). Traditional antipsychotics mainly target dopamine receptors but often inadequately address negative symptoms and cause significant side effects (2). Xanomeline-trospium chloride, a novel

Patient Case Based on Xanomeline-Trospium Chloride in Schizophrenia: Advancing Treatment for Resistant Symptoms
95 Reached
Similar Content

Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2466 Reached4 Comments6 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2253 Reached10 Comments4 Likes

Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes

Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes